首页> 外文OA文献 >Immune expression of E-cadherin and alpha, beta and gamma-Catenin adhesion molecules and prognosis for upper urinary tract urothelial carcinomas
【2h】

Immune expression of E-cadherin and alpha, beta and gamma-Catenin adhesion molecules and prognosis for upper urinary tract urothelial carcinomas

机译:E-cadherin和α,β和γ-Catenin粘附分子的免疫表达及上尿路尿路上皮癌的预后

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Introduction: Cell adhesion molecules (CAM) are required for maintaining a normal epithelial phenotype, and abnormalities in CAM expression have been related to cancer progression, including bladder urothelial carcinomas. There is only one study that correlates E-cadherin and alpha-, beta- and gamma-catenin expression with prognosis of upper tract urothelial carcinomas. Our aim is to study the pattern of immune expression of these CAMs in urothelial carcinomas from the renal pelvis and ureter in patients who have been treated surgically. Our goal is to correlate these expression levels and characteristics with well-known prognostic parameters for disease-free survival. Materials and Methods: We evaluated specimens from 20 patients with urothelial carcinomas of the renal pelvis and ureter who were treated with nephroureterectomy or ureterectomy between June 1997 and January 2007. CAM expression was evaluated by immunohistochemistry in a tissue microarray and correlated with histopathological characteristics and patient outcomes after a mean follow-up of 55 months. Results: We observed a relationship between E-cadherin expression and disease recurrence. Disease recurrence occurred in 87.5% of patients with strong E-cadherin expression. Only 50.0% of patients with moderate expression and 0% of patients with weak or no expression of E-cadherin had disease recurrence (p = 0.014). There was also a difference in disease-free survival. Patients with strong E-cadherin expression had a mean disease-free survival rate of 49.1 months, compared to 83.9 months for patients with moderate expression (p = 0.011). Additionally, an absence of a-catenin expression was associated with tumors that were larger than 3 cm (p = 0.003). Conclusions: We demonstrated for the first time that immune expression of E-cadherin is related to tumor recurrence and disease-free survival rates, and the absence of a-catenin expression is related to tumor size in upper tract urothelial carcinomas.
机译:简介:细胞粘附分子(CAM)是维持正常上皮表型所必需的,并且CAM表达异常与癌症进展相关,包括膀胱尿路上皮癌。仅有一项研究将E-钙粘蛋白和α-,β-和γ-连环蛋白的表达与上尿路尿路上皮癌的预后相关。我们的目的是研究经手术治疗的患者在肾盂和输尿管上皮尿路上皮癌中这些CAMs的免疫表达模式。我们的目标是将这些表达水平和特征与众所周知的无病生存预后参数相关联。材料与方法:我们评估了1997年6月至2007年1月间接受肾结直肠切除术或输尿管切除术治疗的20例肾盂和输尿管尿路上皮癌患者的标本。通过免疫组织化学在组织芯片中评估CAM的表达,并与组织病理学特征和患者相关平均随访55个月后的预后。结果:我们观察到E-钙黏着蛋白表达与疾病复发之间的关系。 E-钙黏着蛋白表达高的患者中有87.5%发生疾病复发。 E-钙粘着蛋白中等表达的患者只有50.0%,E-钙粘蛋白表达弱或没有表达的患者中有0%复发(p = 0.014)。无病生存期也有所不同。 E-钙粘着蛋白表达高的患者平均无病生存期为49.1个月,而中等表达的患者则为83.9个月(p = 0.011)。另外,a-catenin表达的缺失与大于3 cm的肿瘤有关(p = 0.003)。结论:我们首次证明E-钙粘蛋白的免疫表达与肿瘤复发和无病生存率有关,而α-catenin表达的缺失与上尿路尿路上皮癌的大小有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号